XNAS · Healthcare · Medical Care Facilities
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q1 2026 | 0.08 | 0.06 | -25.00% | $44.9M | ❌ Miss | -4.09% | -7.73% | +6.36% |
| 2026-03-11 | Q4 2025 | 0.08 | 0.06 | -25.00% | $46.4M | ❌ Miss | +1.16% | -20.93% | -7.56% |
| 2025-11-05 |
| Q3 2025 |
| 0.09 |
| 0.22 |
| +144.44% |
| $48.0M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-06 | Q2 2025 | 0.10 | 0.10 | +0.00% | $48.9M | ➖ Inline | -11.92% | -20.47% | -10.36% |
| 2025-03-12 | Q4 2024 | 0.17 | 0.10 | -41.18% | $49.8M | ❌ Miss | -25.12% | +2.93% | -10.98% |
| 2024-11-12 | Q3 2024 | 0.09 | 0.33 | +266.67% | $51.4M | ✅ Beat | +21.74% | +10.33% | +18.48% |
| 2024-05-07 | Q1 2024 | 0.03 | -0.06 | -300.00% | $46.8M | ❌ Miss | +5.20% | +3.12% | +16.64% |
| 2024-03-12 | Q4 2023 | 0.08 | 0.18 | +125.00% | $45.7M | ✅ Beat | — | — | — |
Showing last 8 quarters.